Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Zhiping Huang, MD, PhD
Merck Sharp & Dohme, LLC, Rahway, NJ, USA
Poster(s):
(CSPOT17) A post-authorization safety study of golimumab in ulcerative colitis using the Spanish ENEIDA registry (MK8259-042)
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST